BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11509956)

  • 1. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
    Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
    Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
    Lucas ML; Heller L; Coppola D; Heller R
    Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
    Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
    Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.
    Wang Q; Yu H; Ju DW; He L; Pan JP; Xia DJ; Zhang LH; Cao X
    Gene Ther; 2001 Apr; 8(7):542-50. PubMed ID: 11319621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
    Lucas ML; Heller R
    DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective transfer of interleukin-12 gene to solid tumors using a novel gene delivery system, poly [D,L-2,4-diaminobutyric acid].
    Iwashita Y; Ogawa T; Goto S; Nakanishi M; Goto T; Kitano S
    Cancer Gene Ther; 2004 Feb; 11(2):103-8. PubMed ID: 14671674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
    Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
    Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.
    Ju DW; Yang Y; Tao Q; Song WG; He L; Chen G; Gu S; Ting CC; Cao X
    Gene Ther; 2000 Oct; 7(19):1672-9. PubMed ID: 11083476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
    Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
    Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of interleukin 12 to antitumor cytokine and gene therapy.
    Nishimura T; Watanabe K; Yahata T; Ushaku L; Ando K; Kimura M; Saiki I; Uede T; Habu S
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S27-34. PubMed ID: 8765412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.
    Choi IK; Lee JS; Zhang SN; Park J; Sonn CH; Lee KM; Yun CO
    Gene Ther; 2011 Sep; 18(9):898-909. PubMed ID: 21451575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
    J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model.
    Yamashita YI; Shimada M; Hasegawa H; Minagawa R; Rikimaru T; Hamatsu T; Tanaka S; Shirabe K; Miyazaki JI; Sugimachi K
    Cancer Res; 2001 Feb; 61(3):1005-12. PubMed ID: 11221826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
    Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
    Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.
    Kim H; Sin JI
    Hum Vaccin Immunother; 2012 Nov; 8(11):1714-21. PubMed ID: 23151450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
    Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
    Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2.
    Cao X; Zhang W; Gu S; Yu Y; Tao Q; Ye T
    J Cancer Res Clin Oncol; 1995; 121(12):721-8. PubMed ID: 7499443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.